NEW YORK (GenomeWeb) – Hangzhou Berry Genomics has received premarket clearance from the Chinese Food and Drug Administration for its NextSeq CN500, a high-throughput sequencing instrument for non-invasive prenatal testing, and its NIPT kit, according to Berry partner Illumina.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.

The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.

In Science this week: genetic overlap among many psychiatric disorders, and more.

The Economist writes that an increasing number of scientific journals don't do peer review.